Herbas VPB

Print
EN | LT
LT - COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
EN - COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4045
A61K 31/519
European patent
(11) Number of the document 2720696
(13) Kind of document T
(96) European patent application number 12730099.4
Date of filing the European patent application 2012-06-13
(97) Date of publication of the European application 2014-04-23
(45) Date of publication and mention of the grant of the patent 2016-05-25
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/042174
Date 2012-06-13
PCT application publication
(87) Number WO 2012/174061
Date 2012-12-20
Priority applications
(30) Number Date Country code
201161496750 P 2011-06-14 US
201161568717 P 2011-12-09 US
Inventors
(72)
BAFFERT, Fabienne, CH
RADIMERSKI, Thomas, CH
GADBAW, Brian, US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Title
(54) COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
  COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
Last update date 2021-04-30